Analytical method and kit thereof

Details for Australian Patent Application No. 2004226015 (hide)

Owner Phadia AB

Inventors Mahler, Michael

Agent Davies Collison Cave

Pub. Number AU-B-2004226015

PCT Pub. Number WO2004/087745

Priority 0300958-6 02.04.03 SE

Filing date 2 April 2004

Wipo publication date 14 October 2004

Acceptance publication date 8 July 2010

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/525 (2006.01) Peptides having more than 20 amino acids

G01N 33/564 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for pre-existing immune complex or autoimmune disease

Event Publications

10 November 2005 PCT application entered the National Phase

  PCT publication WO2004/087745 Priority application(s): WO2004/087745

21 December 2006 Change of Name(s) of Applicant(s), Section 104

  Pharmacia Diagnostics AB The name of the applicant has been changed to Phadia AB

8 July 2010 Application Accepted

  Published as AU-B-2004226015

4 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226018-Benzodiazepine spirohydantoin CGRP receptor antagonists

2004226011-Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof